Proton Magnetic Resonance Spectroscopy: Ex vivo study to investigate its prognostic role in colorectal cancer

Biomedicine and Pharmacotherapy

Volumn 67, Issue 7, 2013, Pages 593-597

  Minicozzi, Annamaria ^a   Mosconi, Elisa ^b   Cordiano, Claudio ^a   Rubello, Domenico ^c   Marzola, Pasquina ^b   Ferretti, Alice ^c   Maffione, Anna Margherita ^c   Sboarina, Andrea ^a   Bencivenga, Maria ^a   Boschi, Federico ^b   Conti, Giamaica ^b   Sbarbati, Andrea ^b  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c SANTA MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

Author keywords

1H MRS; Choline; Colorectal cancer; Lipids; Tumor metabolism

Indexed keywords

CAPECITABINE;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURGERY; COLORECTAL CANCER; COMPARATIVE STUDY; EX VIVO STUDY; METASTASIS; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

1H MRS; CHOLINE; COLORECTAL CANCER; LIPIDS; TUMOR METABOLISM;

AGED; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MUCOUS MEMBRANE; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROTONS; TUMOR MARKERS, BIOLOGICAL;

EID: 84884821358     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2013.05.002     Document Type: Article

References (21)

1. Kwock L., Smith J.K., Castillo M., et al. Clinical role of proton magnetic resonance spectroscopy in oncology: brain, breast, and prostate cancer. Lancet Oncol 2006, 7:859-868.
2. Jansen J.F.A., Backes W.H., Nicolay K., Eline Kooi M. 1H MR spectroscopy of the brain: absolute quantification of metabolites. Radiology 2006, 240(2):318-332.
3. Mackinnon W.B., Delbridge L., Russell P., et al. Two-dimensional proton magnetic resonance spectroscopy for tissue character ization of thyroid neoplasms. World J Surg 1996, 20(7):841-847.
4. Calabrese C., Pisi A., Di Febo G., et al. Biochemical alterations from normal mucosa to gastric cancer by ex vivo magnetic resonance spectroscopy. Cancer Epidemiol Biomarkers Prev 2008, 17(6):1386-1395.
5. Jansen J.F., Schöder H., Lee N.Y., et al. Tumor metabolism and perfusion in head and neck squamous cell carcinoma: pretreatment multimodality imaging with (1)H Magnetic Resonance Spectroscopy, Dynamic Contrast-Enhanced MRI, and [(18)F]FDG-PET. Int J Radiat Oncol Biol Phys 2012, 82(1):299-307.
6. Bourne R.M., Stanwell P., Stretch J.R., et al. In vivo and ex vivo proton MR spectroscopy of primary and secondary melanoma. Eur J Radiol 2005, 53(3):506-513.
7. Kuo L.J., Chiou J.F., Tai C.J., Chang C.C., et al. Can we predict pathologic complete response before surgery for locally advanced rectal cancer treated with preoperative chemoradiation therapy?. Int J Colorectal Dis 2012, 27(5):613-621.
8. Perez R.O., Habr-Gama A., Pereira G.V., Lynn P.B., Alves P.A., Proscurshim I., et al. Role of biopsies in patients with residual rectal cancer following neoadjuvant chemoradiation after downsizing: can they rule out persisting cancer?. Colorectal Dis 2012, 14(6):714-720.
9. Chan E.C., Koh P.K., Mal M., Cheah P.Y., et al. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS). Proteome Res 2009, 8(1):352-361.
10. Jordan K.W., Nordenstam J., Lauwers G.Y., et al. Metabolomic characterization of human rectal adenocarcinoma with intact tissue magnetic resonance spectroscopy. Dis Colon Rectum 2009, 52(3):520-525.
11. Lean C.L., Newland R.C., Ende D.A., et al. Assessment of human colorectal biopsies by 1H MRS: correlation with histopathology. Magn Reson Med 1993, 30(5):525-533.
12. Ratiney H., Sdika M., Coenradie Y., et al. Time-domain semi-parametric estimation based on a metabolite basis set. NMR Biomed 2005, 18:1-13.
13. Naressi A., Couturier C., Castang I.R., et al. Java-based graphical user interface for MRUI, a software package for quantitation of in vivo/medical magnetic resonance spectroscopy signals. Comp Bio Med 2001, 31:269-286.
14. Ratiney H., Coenradie Y., Cavassila S., et al. Time domain quantitation of 1H short echo-time signals: background accomodation. MAGMA 2004, 16(6):284-296.
15. Kuo Y.T., Li C.W., Chen C.Y., et al. In vivo proton magnetic resonance spectroscopy on large focal hepatic lesions and metabolite change of hepatocellular carcinoma before and after transcatheter arterial chemoembolization using 3.0T MR scanner. J Magn Reson Imaging 2004, 19:598-604.
16. Wu B., Peng W.J., Wang P.J., et al. In vivo 1H magnetic resonance spectoscopy in evaluation of hepatocellular carcinoma and its early resposnse to transcatheter arterial chemoemobilization. Chin Med Sci J 2006, 21(4):258-264.
17. Gadian D.G. Magnetic resonance spectroscopy as a probe of tumour metabolism. Eur J Cancer 1991, 27(5):526-528.
18. Bezabeh T., Smith I.C., Krupnik E., et al. Diagnostic potential for cancer via 1H magnetic resonance spectroscopy of colon tissue. Anticancer Res 1996, 16:1553-1558.
19. Dzik-Jurasz A.S.K., Murphy P.S., Gorge M., et al. Human rectal adenocarcinoma: demonstration of 1H-MRSpectra in vivo at 1.5T. Magn Reson Med 2002, 47:809-811.
20. Kim M.J., Lee S.J., Lee J.H., et al. Detection of rectal cancer and response to concurrent chemoradiotherapy by proton magnetic resonance spectroscopy. Magn Reson Imaging 2012, 30(6):848-853.
21. Canese R., Iorio E., Ricci A., Pisanu M.E., Giannini M., Podo F. Metabolite quantification in tumours by magnetic resonance spectroscopy: objectives. Results and perspectives. Curr Med Imaging Rev 2009, 5(2):110-127.